The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy.

Armuzzi, A; Cremonini, F; Bartolozzi, F; Canducci, F; Candelli, M; Ojetti, V; Cammarota, G; Anti, M; De Lorenzo , A; Pola, P; Gasbarrini, G; Gasbarrini, A

Armuzzi, A; Cremonini, F; Bartolozzi, F; Canducci, F; Candelli, M; Ojetti, V; Cammarota, G; Anti, M; De Lorenzo , A; Pola, P; Gasbarrini, G; Gasbarrini, A.

Affiliation

Armuzzi A; Department of Internal Medicine, Catholic University, Rome, Italy.

Aliment Pharmacol Ther ; 15(2): 163-9, 2001 Feb.

Article in En | MEDLINE | ID: mdl-11148433

Subject(s)

Anti-Ulcer Agents/therapeutic use; Helicobacter Infections/drug therapy; Lactobacillus; Probiotics/therapeutic use; 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents/adverse effects; Benzimidazoles/adverse effects; Benzimidazoles/therapeutic use; Clarithromycin/adverse effects; Clarithromycin/therapeutic use; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter pylori/drug effects; Humans; Male; Omeprazole/analogs & derivatives; Prospective Studies; Rabeprazole; Tinidazole/adverse effects; Tinidazole/therapeutic use; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Helicobacter Infections / Probiotics / Lactobacillus / Anti-Ulcer Agents Type of study: Clinical_trials / Etiology_studies / Observational_studies Language: En Journal: Aliment Pharmacol Ther Year: 2001 Type: Article Affiliation country: Italy

Search on Google

Add to My VHL

XML

PubMed Links